Impact of macrolides antibiotics in mortality of patients infected by HIV with community-acquired pneumonia.
Not Applicable
- Conditions
- Pneumonia, HIV.B20-B24
- Registration Number
- RBR-8wtq2b
- Lead Sponsor
- Instituto de Infectologia Emílio Ribas
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Age over 18 years; HIV infection and community acquired pneumonia.
Calculated sample: 228.
Exclusion Criteria
Patients with hospitalization for two or more days in the 90 days prior to admission; coming from nursing homes or shelters; if they had health care in those sites; patients that had received intravenous antibiotics; chemotherapy or treatment of bedsores in the last 30 days; in dialysis; with another cause that justifies the lung symptoms on admission; such as pulmonary fibrosis; pneumocystosis; tuberculosis or other non-bacterial disease; pregnant or nursing women; patients allergic to the study medications (ceftriaxone and azithromycin) or patients that had already been randomized in this study.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method